Community/Retail

Continuous glucose monitoring (CGM) significantly enhances the detection of cystic fibrosis-related diabetes, outperforming traditional methods.

Two experts discuss sessions that covered perimenopause, premature ovarian insufficiency, GLP-1–based treatments, and the health needs of Indigenous and Hispanic women.

Influenza significantly impacts agricultural workers in the Americas, highlighting urgent vaccination needs for public health and food security.

Steps must be made to preserve pharmacy access for those who need it most.

The FDA designates Stoboclo and Osenvelt as interchangeable biosimilars for denosumab, enhancing treatment options for osteoporosis and cancer-related conditions.

Low RSV vaccination rates among older adults in the US highlight missed opportunities for reducing hospitalizations and healthcare costs.

Explore the impact of GLP-1 medication on weight loss in menopausal women, highlighting the need for personalized treatment approaches.

Long-term benzodiazepine use has been linked to lasting cognitive impairments, underscoring the vital role pharmacists play in supporting safe deprescribing strategies.

Pharmacists play a crucial role in supporting women through menopause, offering education on treatments, side effects, and long-term health management.

New strategies target dormant tumor cells in breast cancer, offering hope for preventing recurrence and transforming patient management.

FDA designates Conexxence and Bomyntra as interchangeable denosumab biosimilars, enhancing access and affordability for patients needing critical therapies.

Pharmacists play a vital role in vaccine education and administration.

FDA accelerated approval speeds access but faces challenges with trial completion, costs, and end point validation.

Pharmacists explore estrogen replacement therapy for young women with POI, discussing safe options and alternatives for managing menopause symptoms.

Environmental factors significantly influence the rising rates of type 2 diabetes in children.

The agency announced that human clinical trials will no longer be required in lieu of a comparative analytical assessment to determine biosimilar equivalency with its reference product.

Liposomal vitamin C enhances bioavailability, offering superior absorption and antioxidant benefits compared with traditional forms, promising better health outcomes.

Heavy workloads, lack of recognition, and stressful environments fuel emotional exhaustion, turnover, and patient safety concerns.

Missteps in prescribing and counseling can escalate into catastrophic harm and significant financial liability.

Recent research reveals rising cancer rates among younger and older adults, linking obesity to increased incidence.

Pharmacist Care Day showcased UPMC Health Plan’s commitment to whole-person care through free health services, pharmacist-led outreach, and strong community collaborations in Pittsburgh.

Christina Barrington, PharmD, champions pharmacists' vital role in enhancing health care access and quality, advocating for their recognition as essential providers.

In Danish athletes, long-term anabolic androgenic steroid use was associated with progressively worsened cardiovascular outcomes.

The FDA approves a simplified single-injection treatment for ulcerative colitis, enhancing patient experience with monthly dosing convenience.

A new low-carbon albuterol inhaler shows therapeutic equivalence to original options, suggesting reduced emissions and improved sustainability for patients with asthma and other respiratory conditions.

Explore the role of pharmacists in managing menopause-related vasomotor symptoms with innovative non-hormonal therapies like Elinzanetant.

Total cholesterol and triglyceride levels were linked to an increased risk of Alzheimer-related declines in cognitive function, whereas high-density lipoprotein cholesterol provided a protective effect.

Lawmakers weigh cost concerns, clinical outcomes, and regulatory barriers as access to these medications evolves.